Pancreatic endocrine tumours: Mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries

V. Corbo, S. Beghelli, S. Bersani, D. Antonello, G. Talamini, M. Brunelli, P. Capelli, M. Falconi, A. Scarpa

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Kinases represent potential therapeutic targets in pancreatic endocrine tumours (PETs).Patients and methods: Thirty-five kinase genes were sequenced in 36 primary PETs and three PET cell lines: (i) 4 receptor tyrosine kinases (RTK), epithelial growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), tyrosine-protein kinase KIT (KIT), platelet-derived growth factor receptor alpha (PDGFRalpha); (ii) 6 belonging to the Akt/mTOR pathway; and (iii) 25 frequently mutated in cancers. The immunohistochemical expression of the four RTKs and the copy number of EGFR and HER2 were assessed in 140 PETs.Results: Somatic mutations were found in KIT in one and ATM in two primary neoplasms. Among 140 PETs, EGFR was immunopositive in 18 (13%), HER2 in 3 (2%), KIT in 16 (11%), and PDGFRalpha in 135 (96%). HER2 amplification was found in 2/130 (1.5%) PETs. KIT membrane immunostaining was significantly associated with tumour aggressiveness and shorter patient survival. PET cell lines QGP1, CM and BON harboured mutations in FGFR3, FLT1/VEGFR1 and PIK3CA, respectively.Conclusions: Only rare PET cases, harbouring either HER2 amplification or KIT mutation, might benefit from targeted drugs. KIT membrane expression deserves further attention as a prognostic marker. ATM mutation is involved in a proportion of PET. The finding of specific mutations in PET cell lines renders these models useful for preclinical studies involving pathway-specific therapies.

Original languageEnglish
Article numbermdr048
Pages (from-to)127-134
Number of pages8
JournalAnnals of Oncology
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 2012

Keywords

  • Carcinoma
  • Endocrine
  • Kinases
  • Pancreas
  • Therapy

ASJC Scopus subject areas

  • Oncology
  • Hematology

Fingerprint

Dive into the research topics of 'Pancreatic endocrine tumours: Mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries'. Together they form a unique fingerprint.

Cite this